
For laboratory research use only. Not for human consumption.
Cagrilintide Peptide For Sale
A synthetic peptide analog utilized in controlled laboratory research environments.
Dosage
Quantity
Bundle & Save
From
$39.99Type
Research Peptide
Category
Peptides
Batch
SBP-001
Batch number
SBP-001
Tested date
4/7/2026
What is Calgrilinitide?
Calgrilinitide (Calgrilinitide) is offered as a research reference material for qualified analytical and in vitro laboratory workflows. This compound is produced under controlled conditions to ensure consistency and analytical reliability. Intended strictly for laboratory research use only. Not for human consumption.
How it Works
In research settings, Calgrilinitide is used to probe defined biological pathways under controlled laboratory conditions. Mechanistic studies typically combine receptor or cell-based assays with analytical verification of peptide identity and integrity.
Purity & Testing
99% minimum purity (per specification / COA for the active batch). Each lot is tied to batch documentation so researchers can align material received with COA and specification records before use in regulated workflows. Request a COA from this page if you need documentation prior to purchase.
Storage & Handling
Store per label and COA. Follow proper laboratory handling and preparation protocols.
Research Overview
A synthetic peptide analog utilized in controlled laboratory research environments.
Specifications
| Compound | Calgrilinitide |
|---|---|
| Presentation | 10mg |
| Purity | 99% |
| Catalog reference period | 56 days |
Sources & References
Peer-reviewed research
Lancet
Safety, tolerability, pharmacokinetics, and pharmacodynamics of concomitant administration of multiple doses of cagrilintide with semaglutide 2·4 mg
2021 · DOI: 10.1016/S0140-6736(21)01751-7 · PMID: 34555336
Enebo LB, Berthelsen KK, Kankam M, et al.
View SourceNew England Journal of Medicine
Once-Weekly Cagrilintide for Weight Management in People with Overweight and Obesity
2021 · DOI: 10.1016/S0140-6736(21)01751-7 · PMID: 34672949
Lau DCW, Erichsen L, Francisco AM, et al.
View SourceDiabetologia
Cagrilintide and semaglutide combination in obesity and type 2 diabetes
2023 · DOI: 10.1007/s00125-023-05975-8 · PMID: 37368073
Frias JP, Deenadayalan S, Erichsen L, et al.
View SourceThe New England journal of medicine
Coadministered Cagrilintide and Semaglutide in Adults with Overweight or Obesity
2025 · DOI: 10.1056/NEJMoa2502081 · PMID: 40544433
Garvey WT, Blüher M, Osorto Contreras CK, et al.
View SourceThe New England journal of medicine
Cagrilintide-Semaglutide in Adults with Overweight or Obesity and Type 2 Diabetes
2025 · DOI: 10.1056/NEJMoa2502082 · PMID: 40544432
Davies MJ, Bajaj HS, Broholm C, et al.
View SourceLancet (London, England)
Once-weekly cagrilintide for weight management in people with overweight and obesity: a multicentre, randomised, double-blind, placebo-controlled and active-controlled, dose-finding phase 2 trial
2021 · DOI: 10.1016/S0140-6736(21)01751-7 · PMID: 34798060
Lau DCW, Erichsen L, Francisco AM, et al.
View SourceLancet (London, England)
Efficacy and safety of co-administered once-weekly cagrilintide 2·4 mg with once-weekly semaglutide 2·4 mg in type 2 diabetes: a multicentre, randomised, double-blind, active-controlled, phase 2 trial
2023 · DOI: 10.1016/S0140-6736(23)01163-7 · PMID: 37364590
Frias JP, Deenadayalan S, Erichsen L, et al.
View SourceIndian journal of endocrinology and metabolism
Efficacy and Safety of Cagrilintide Alone and in Combination with Semaglutide (Cagrisema) as Anti-Obesity Medications: A Systematic Review and Meta-Analysis
2024 · DOI: 10.4103/ijem.ijem_45_24 · PMID: 39676787
Dutta D, Nagendra L, Harish BG, et al.
View SourceCardiology in review
Cagrilintide: A Long-Acting Amylin Analog for the Treatment of Obesity
2024 · DOI: 10.1097/CRD.0000000000000513 · PMID: 36883831
D'Ascanio AM, Mullally JA, Frishman WH
View SourceJournal of medicinal chemistry
Development of Cagrilintide, a Long-Acting Amylin Analogue
2021 · DOI: 10.1021/acs.jmedchem.1c00565 · PMID: 34288673
Kruse T, Hansen JL, Dahl K, et al.
View SourceFrequently Asked Questions
- What is Calgrilinitide used for in research?
- Calgrilinitide is supplied strictly as a research reference material for qualified in vitro and analytical laboratory workflows. It is not intended for human or veterinary use, diagnosis, or therapeutic application.
- How is Calgrilinitide purity verified?
- Batches are accompanied by specification documentation and Certificate of Analysis (COA) data where available. Review the product page and request COA details before incorporating material into regulated studies.
- How should Calgrilinitide be stored?
- Store lyophilized material according to the label and COA. After reconstitution, follow your institutional SOP for temperature, light exposure, and working-solution stability.
- Who can purchase Calgrilinitide from Science Based Peptides?
- Catalog items are sold to qualified researchers and laboratories for research use only. Buyers must confirm age and research-use eligibility before checkout.
- Does Science Based Peptides ship Calgrilinitide in the USA?
- Yes — we fulfill research peptide orders to qualified customers in the United States subject to product availability and our shipping policies listed at checkout.
Related Products
Request Certificate of Analysis (COA)
Need documentation for this product? Submit your name and email and we will send COA details.



